Article

PREDICTORS OF PERSISTENT LEFT VENTRICULAR DYSFUNCTION AFTER SPONTANEOUS CORONARY ARTERY DISSECTION: A REPORT OF THE ISCAD REGISTRY

Authors:
Stanislav Henkin
Stanislav Henkin
Stanislav Henkin
  • This person is not on ResearchGate, or hasn't claimed this research yet.
Malissa J. Wood
Malissa J. Wood
Malissa J. Wood
  • This person is not on ResearchGate, or hasn't claimed this research yet.
Grodzinsky
Grodzinsky
Grodzinsky
  • This person is not on ResearchGate, or hasn't claimed this research yet.
Heather Gornik at Cleveland Clinic
Heather Gornik
Show all 22 authorsHide
Download citation
To read the full-text of this research, you can request a copy directly from the authors.

No full-text available

Request Full-text Paper PDF

To read the full-text of this research,
you can request a copy directly from the authors.

... Most patients had a normal LVEF during follow-up, which is consistent with other published data [44]. A trend to a lower proportion of patients with persisting severely reduced LVEF is in line with the lower need of intensive care treatment over time in this study, and might hint towards an improved management of patients, even if MACE rates are not yet affected. ...
View
Spontaneous coronary artery dissection in regions of non-Western populations: a systematic literature search and scoping review
Article
  • Mar 2025
Current data on spontaneous coronary artery dissection (SCAD) predominantly originates from Europe or Caucasians with limited information about other ethnicities. This scoping review presents the evidence on SCAD in non-Western countries. The prevalence of SCAD diagnosis was 1.0% (95% CI: 0.0–3.0, I2=99%) among patients presenting with myocardial infarction, increasing to 5.0% (95% CI: 1.0–16.0, I2=99%) among females. The mean age was 51.3 years with females accounting for 54.0% of patients. A conservative revascularization management was reported in 48.0% (95% CI: 32.0–65.0, I2=85%) of patients. Antiplatelet therapy was reported as dual (68.0%, 95% CI: 37.0–89.0, I2=90%) in only three studies. A death rate (3.0%) was similar during hospitalization and at mean follow-up of 23.42 months. In conclusion, there is a marked variability in the clinical course of SCAD patients as well heterogeneity among the included studies. This review identified knowledge gaps in our understanding of SCAD in non-Western countries that should be addressed in future prospective studies.
View
ResearchGate has not been able to resolve any references for this publication.